Results of a vaccination campaign against human papillomavirus in the province of La Spezia, Liguria, Italy, March-December 2008.
Sexually transmitted diseases caused by human papillomavirus (HPV) are being diagnosed more frequently than others. It is accepted that HPV infection is a necessary cause for all cases of cervical carcinoma and a large number of other anogenital and oral cancers. Two vaccines have been developed and were licensed in 2007, which can prevent infections and pre-cancerous lesions due to HPV. In Italy pre-adolescent age (12 years-old) was identified as the ideal age for vaccination against HPV. In Liguria, the first free HPV vaccination campaign was started on 8 March 2008 in 12 year-old girls. We assessed the adherence to the vaccination during the 2008 campaign as 80.6%, 79.0% and 64.1%, respectively, for the first, second and third dose of vaccine in the target population.
Lugarini
J
J
Department of Health Sciences, University of Genoa, Italy. jessica.lugarini@unige.it
Maddalo
F
F
D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D006293:Health Promotion / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D032541:Mass Vaccination / Q000706:statistics & numerical data*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D011159:Population Surveillance; D015397:Program Evaluation; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013219:State Government; D016896:Treatment Outcome
D053918:Papillomavirus Vaccines